Join the Ingrezza group to help and get support from people like you.
Ingrezza News
Neurocrine Biosciences Announces U.S. FDA Approval of Ingrezza Sprinkle (valbenazine) Capsules
SAN DIEGO, April 30, 2024 /PRNewswire/ – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration has approved Ingrezza Sprinkle (valbenazine) capsules, a...
Neurocrine Biosciences Announces FDA Approval of Ingrezza (valbenazine) Capsules for the Treatment of Chorea Associated With Huntington's Disease
SAN DIEGO, Aug. 18, 2023 /PRNewswire/ – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the U.S. Food and Drug Administration (FDA) has approved Ingrezza® (valbenazine) capsules for the ...
Valbenazine Yields Improvement in Chorea in Huntington Disease
MONDAY, June 12, 2023 – Valbenazine results in improvement in chorea compared with placebo for patients with Huntington disease, according to a study published in the June issue of The Lancet...
Neurocrine Announces FDA Approval of Ingrezza (valbenazine) as the First and Only Approved Treatment for Adults with Tardive Dyskinesia (TD)
SAN DIEGO, April 11, 2017 /PRNewswire/ – Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the U.S. Food and Drug Administration (FDA) has approved Ingrezza (valbenazine) capsules for...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Tardive Dyskinesia, Huntington's Disease